Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chemoxy International is a prominent European contract development and manufacturing organization (CDMO) specializing in custom synthesis and solvent recovery. Based in the United Kingdom, the company provides critical chemical processing services to the pharmaceutical, agrochemical, personal care, and specialty chemical sectors. Their core expertise includes complex reactions such as esterification, transesterification, and high-vacuum distillation, often utilized in the production of active pharmaceutical ingredients (APIs) and high-purity intermediates. Following its acquisition by Seqens in 2017, Chemoxy operates as a key part of a global network, leveraging its two major manufacturing sites in Middlesbrough and Billingham to serve an international client base. The company is also recognized for its development of environmentally friendly, low-toxicity solvents used in various industrial applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chemoxy International.